With the news that an anonymous benefactor has donated £20 million to Cancer Research UK and the University of Southampton for the advancement of cancer immunotherapies, we discuss the direction of such therapies and the promise that they hold in curing numerous cancers. Is £20 million enough, however, and how can what limited funding there is be used efficiently in the current economic maelstrom?
Find out at the Trenches of Discovery.
